Lidocaine Hydrochloride Monohydrate, Methylprednisolone Acetate

25 trials 9 recruiting HEndocrinology

Filter these 25 trials by condition, phase, country and more.

Open in Search →

25 Registered trials

9 Recruiting

10 Completed trials

17 Sponsors

22 Countries

Phase III

Phase II

Phase I (FiH)

Phase III: 9 Phase II/III: 1 Phase II: 10 Phase IV: 1 Phase I (FiH): 4

Oversight events:

1 urgent safety measure 1 unexpected event across 2 trials

View oversight register →

Indications tested

Crigler-Najjar syndrome 2 Muscular dystrophy 2 Plasma cell myeloma 2 Non-small cell lung cancer metastatic 1 Lupus nephritis 1 Neuroendocrine cell hyperplasia of infancy 1 IgA nephropathy 1 Primary progressive multiple sclerosis 1 Erythema multiforme 1 End stage renal disease 1 Multiple sclerosis 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 3 F. Hoffmann-La Roche AG 3 Sanofi-Aventis Recherche & Developpement 3 Atamyo Therapeutics 2 Genethon 2 Asociacion Instituto De Investigacion Sanitaria Bioaraba 1 Biogen Idec Research Limited 1 Consorci Mar Parc De Salut De Barcelona 1 Crinetics Pharmaceuticals Inc. 1 Genmab A/S 1 Insel Gruppe AG 1 Kite Pharma Inc. 1

All trials — page 2

25 total

A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma Ended

2023-505169-10-00 Phase II 1 country Kite Pharma Inc.

Showing 25–25 of 25 trials

← All drugs A–Z